Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Orchestra BioMed Holdings, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
OBIO
Nasdaq
3841
www.orchestrabiomed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Orchestra BioMed Holdings, Inc.
Orchestra BioMed Announces Pricing of Public Offering
- Nov 5th, 2026 8:42 pm
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
- Nov 5th, 2026 5:00 pm
Orchestra BioMed Announces Proposed Public Offering
- Nov 5th, 2026 2:01 pm
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
- Oct 29th, 2026 6:30 am
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
- Oct 22nd, 2026 6:30 am
OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports
- Oct 20th, 2026 12:35 pm
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
- Oct 1st, 2026 6:00 am
Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?
- Sep 21st, 2026 5:33 am
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
- Sep 16th, 2026 6:30 am
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
- Sep 15th, 2026 6:30 am
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Aug 27th, 2026 6:30 am
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
- Aug 20th, 2026 6:30 am
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates
- Aug 10th, 2026 3:55 pm
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
- Aug 10th, 2026 2:12 pm
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
- Jun 29th, 2026 6:00 am
Sidoti Events, LLC's June Small-Cap Virtual Conference
- Jun 16th, 2026 8:00 am
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jun 2nd, 2026 2:05 pm
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock
- May 21st, 2026 5:10 am
Scroll